Table 1 Baseline characteristics of naïve and experienced users of osteoporotic medication after hip fracture.
Characteristics | Naïve (n = 2,184) | Experienced (n = 2,672) | Total (n = 4,856) | % | p value | |||
|---|---|---|---|---|---|---|---|---|
N | % | N | % | N | ||||
Socio-demographic | ||||||||
Gender | women | 1,815 | 83.1 | 2,427 | 90.8 | 4,242 | 87.4 | <0,001 |
men | 369 | 16.9 | 245 | 9.2 | 614 | 12.6 | ||
Age | 65–74 | 312 | 14.3 | 422 | 15.8 | 734 | 15.1 | 0.001 |
75–84 | 1,117 | 51.1 | 1,464 | 54.8 | 2,581 | 53.2 | ||
≥ 85 | 755 | 34.6 | 786 | 29.4 | 1,541 | 31.7 | ||
Severity | ||||||||
Previous fracture | Yes | 285 | 13.1 | 627 | 23.5 | 912 | 18.8 | <0,001 |
No | 1,899 | 86.9 | 2,045 | 76.5 | 3,944 | 81.2 | ||
Charlson Index | 0 | 899 | 41.2 | 1,149 | 43.0 | 2,048 | 42.2 | 0.357 |
1 | 631 | 28.9 | 766 | 28.7 | 1,397 | 28.8 | ||
>= 2 | 654 | 29.9 | 757 | 28.3 | 1,411 | 29.1 | ||
Health Services Use | ||||||||
Primary care visits | 0–4 | 537 | 24.6 | 372 | 13.9 | 909 | 18.7 | <0,001 |
5–12 | 810 | 37.1 | 910 | 34.1 | 1,720 | 35.4 | ||
13 | 837 | 38.3 | 1,390 | 52.0 | 2,227 | 45.9 | ||
ER visits | 0 | 1,367 | 64 | 1,598 | 59.8 | 2,995 | 61.7 | 0.008 |
1 | 428 | 19.6 | 559 | 20.9 | 987 | 20.3 | ||
>= 2 | 359 | 16.4 | 515 | 19.3 | 874 | 18.0 | ||
Hospital visits | Yes | 382 | 17.5 | 521 | 19.5 | 903 | 18.6 | 0.074 |
No | 1,802 | 82.5 | 2,151 | 80.5 | 3,953 | 81.4 | ||
Polypharmacy | 0–5 | 508 | 23.3 | 243 | 9.1 | 751 | 15.5 | <0,001 |
6–12 | 1,256 | 57.5 | 1,539 | 57.6 | 2,795 | 57.6 | ||
≥13 | 420 | 19.2 | 890 | 33.3 | 1,310 | 27.0 | ||
Comorbidities | ||||||||
Osteoporosis | Yes | 121 | 5.5 | 746 | 27.9 | 867 | 17.9 | <0,001 |
No | 2,063 | 94.5 | 1,926 | 72.1 | 3,989 | 82.2 | ||
Parkinson | Yes | 94 | 4.3 | 136 | 5.1 | 230 | 4.7 | 0.200 |
No | 2,090 | 95.7 | 2,536 | 94.9 | 4,626 | 95.3 | ||
Dementia | Yes | 348 | 15.9 | 425 | 15.9 | 773 | 15.9 | 0.979 |
No | 1,836 | 84.1 | 2,247 | 84.1 | 4,083 | 84.1 | ||
Diabetes | Yes | 655 | 30 | 658 | 24.6 | 1,313 | 27.0 | <0,001 |
No | 1,529 | 70 | 2,014 | 75.4 | 3,543 | 73.0 | ||
Rheumatoid Artritis | Yes | 51 | 2.3 | 95 | 3.6 | 146 | 3.0 | 0.013 |
No | 2,133 | 97.7 | 2,577 | 96.4 | 4,710 | 97.0 | ||
Stroke | Yes | 217 | 9.9 | 215 | 8.0 | 432 | 8.9 | 0.021 |
No | 1,967 | 90.1 | 2,457 | 92.0 | 4,424 | 91.1 | ||
Myocardial infarction | Yes | 199 | 9.1 | 236 | 8.8 | 435 | 9.0 | 0.735 |
No | 1,985 | 90.9 | 2,436 | 91.2 | 4,421 | 91.0 | ||
Heart failure | Yes | 164 | 7.5 | 183 | 6.9 | 347 | 7.2 | 0.374 |
No | 2,020 | 92.5 | 2,489 | 93.1 | 4,509 | 92.9 | ||
Cancer | Yes | 212 | 9.7 | 303 | 11.3 | 515 | 10.6 | 0.066 |
No | 1,972 | 90.3 | 2,369 | 88.7 | 4,341 | 89.4 | ||
Medication | ||||||||
Osteoporosis–injectable | Yes | 286 | 13.1 | 148 | 5.5 | 434 | 8.9 | <0,001 |
No | 1,898 | 86.9 | 2,524 | 94.5 | 4,422 | 91.1 | ||
Opioid treatment | Yes | 421 | 19.3 | 918 | 34.4 | 1,339 | 27.6 | <0,001 |
No | 1,763 | 80.7 | 1,754 | 65.6 | 3,517 | 72.4 | ||
Sedative treatment | Yes | 1,131 | 51.8 | 1,551 | 58.1 | 2,682 | 55.2 | <0,001 |
No | 1,053 | 48.2 | 1,121 | 41.9 | 2,174 | 44.8 | ||
SSRI treatment | Yes | 421 | 19.3 | 705 | 26.4 | 1,126 | 23.2 | <0,001 |
No | 1,763 | 80.7 | 1,967 | 73.6 | 3,730 | 76.8 | ||
